Translational Session
Hot Topics in Lupus Nephritis
November 07, 2025 | 04:30 PM - 06:00 PM
Location: General Assembly A, Convention Center
Session Description
This session provides a comprehensive update in the current management of lupus nephritis and discusses therapeutic developments in lupus nephritis.
Support for all sessions in the Glomerular Diseases Learning Pathway is provided by an educational grant from Vera Therapeutics, Inc.
Learning Objective(s)
- Identify therapeutic goals in lupus nephritis
- Describe current and future approaches to target pathogenic antibody production
- Describe current and future anti-inflammatory approaches in lupus nephritis
- Define the role of new biomarkers in assessing activity in lupus nephritis
Learning Pathway(s)
- Glomerular Diseases
Moderators
Presentations
- What Should Our Treatment Goals Be for Lupus Nephritis in 2025?
04:30 PM - 04:50 PM
- Assessing Kidney Involvement in Systemic Lupus Erythematosus: Is a Biopsy Always Necessary?
04:50 PM - 05:10 PM
- What Is the Best Way to Target Pathogenic Autoantibody Production in Lupus Nephritis?
05:10 PM - 05:30 PM
- Will Complement Inhibition Have a Place in the Treatment of Lupus Nephritis?
05:30 PM - 05:50 PM
- Q&A
05:50 PM - 06:00 PM